← Leaderboards
Jeffrey L Bennett
University Of Colorado Denver
$6,992,785
Attributed
$9,650,470
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,650,470 · 7
By mechanism
R01$7,073,742 · 3
U24$1,273,996 · 1
K08$458,586 · 1
R03$458,131 · 1
R21$386,015 · 1
Top collaborators
- Wendy B Macklin5 shared
- Timothy A Benke3 shared
- Amanda L Piquet3 shared
- Oliver W Gramlich2 shared
- Gregory Parks Owens2 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Donald Gilden$19,848,267
- Mark P Burgoon$3,107,119
- Gregory Parks Owens$1,946,562
- Wendy B Macklin$14,857,442
- Andrew S Lapato$157,407
Others in their field
Top investigators on “Complement”
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$128,874,888
- Wafaa M. El-Sadr · Columbia University Health Sciences$101,800,876
- Myron S Cohen · Family Health International$101,800,876
- Steve Riordan · Westat, Inc.$94,143,268
- David R. Weir · University Of Michigan At Ann Arbor$93,718,087
- Stuart L Schreiber · Harvard University (Medical School)$88,512,978
Research focus
ComplementResponseCellsNeurologicMediatingIn VivoInflammatoryRecombinant AntibodyAntibodiesImmunoglobulin GDemyelinationsAutoantibodiesLesionBrainCentral Nervous System InjuryInjuryDisabilityCentral Nervous System Demyelinating DisorderTissuesMyelinOligodendrogliaCerebrospinal FluidNeuraxisIn Vivo Model
Grant awards (28)
University of Colorado Rocky Mountain NeuroNEXT (UNCOMON) Clinical Research Consortium.$428,955
U24 · FY2025 · NS · contact PI
Contribution of antibodies targeting PLP1-anchored membrane domains to multiple sclerosis pathogenesis$406,815
R01 · FY2025 · NS · contact PI
Microglial impact on remyelination$472,792
R01 · FY2024 · NS
University of Colorado Rocky Mountain NeuroNEXT (UNCOMON) Clinical Research Consortium.$416,086
U24 · FY2024 · NS · contact PI
Contribution of antibodies targeting PLP1-anchored membrane domains to multiple sclerosis pathogenesis$405,282
R01 · FY2024 · NS · contact PI
Microglial impact on remyelination$487,413
R01 · FY2023 · NS
University of Colorado Rocky Mountain NeuroNEXT (UNCOMON) Clinical Research Consortium.$428,955
U24 · FY2023 · NS · contact PI
Microglial impact on remyelination$487,413
R01 · FY2022 · NS
Humoral Immunity, Astrocyte Injury, and Demyelination in Neuromyelitis Optica$377,088
R01 · FY2022 · EY · contact PI
In vivo modeling of autoantibody-induced optic neuritis$171,564
R21 · FY2022 · EY
Microglial impact on remyelination$487,413
R01 · FY2021 · NS
Humoral Immunity, Astrocyte Injury, and Demyelination in Neuromyelitis Optica$377,087
R01 · FY2021 · EY · contact PI
In vivo modeling of autoantibody-induced optic neuritis$214,451
R21 · FY2021 · EY
Microglial impact on remyelination$483,565
R01 · FY2020 · NS
Humoral Immunity, Astrocyte Injury, and Demyelination in Neuromyelitis Optica$388,750
R01 · FY2020 · EY · contact PI
Humoral Immunity, Astrocyte Injury, and Demyelination in Neuromyelitis Optica$388,750
R01 · FY2019 · EY · contact PI
Humoral Immunity, Astrocyte Injury, and Demyelination in Neuromyelitis Optica$388,750
R01 · FY2018 · EY · contact PI
Humoral Immunity, Astrocyte Injury, and Demyelination in Neuromyelitis Optica$388,750
R01 · FY2017 · EY · contact PI
Humoral Immunity, Astrocyte Injury, and Demyelination in Neuromyelitis Optica$388,750
R01 · FY2016 · EY · contact PI
Humoral Immunity, Astrocyte Injury, and Demyelination in Neuromyelitis Optica$380,362
R01 · FY2015 · EY · contact PI
Humoral Immunity, Astrocyte Injury, and Demyelination in Neuromyelitis Optica$379,137
R01 · FY2014 · EY · contact PI
Humoral Immunity, Astrocyte Injury, and Demyelination in Neuromyelitis Optica$385,625
R01 · FY2013 · EY · contact PI
Antigen Identification in Occult Chorioretinopathies$150,381
R03 · FY2006 · EY · contact PI
Antigen Identification in Occult Chorioretinopathies$154,000
R03 · FY2005 · EY
Antigen Identification in Occult Chorioretinopathies$153,750
R03 · FY2004 · EY
GROWTH FACTORS IN MAMMALIAN EYE DEVELOPMENT$152,862
K08 · FY2002 · EY
GROWTH FACTORS IN MAMMALIAN EYE DEVELOPMENT$152,862
K08 · FY2001 · EY
GROWTH FACTORS IN MAMMALIAN EYE DEVELOPMENT$152,862
K08 · FY2000 · EY